Fingolimod

And this is the thing that you are telling me to do.

If you have a patient with Fingolimod, why are you telling me that the only approved therapy right now from your site has an authority will be teriflunomide? Give me something better.

Here's the evidence.

20,000 patients, give me something better.

And they see that these mice have and look at they see that they have more monocyte derived macrophages within the myeloid cell compartment and that there's a high upregulation of IL-1 beta in these mice in this mouse system and that there's more IgA in the system, too.

And then they use a drug, FTY-720, which is, I believe it blocks macrophage migration.

They don't actually explain what it does in there.

If you go to the abstract, I think the other name for it is, hold on here.